Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Samrat PharmachemBOM:530125 +1.65%64 Days Inventory is 56.28 as of Mar. 2026, which is 65% above its 10-year median of 34.20. GuruFocus rates BOM:530125 with a GF Score™ of 64/100 and a GF Value™ of ₹362.76 (Significantly Undervalued). The stock has 3 warning signs investors should review. Among 1,540 Chemicals companies, Samrat Pharmachem ranks better than 75.06% on this metric.
The historical rank and industry rank for Samrat Pharmachem's Days Inventory or its related term are showing as below:
BOM:530125'
s Days Inventory Range Over the Past 10 Years
Min: 22.44 Med: 34.2 Max: 52.63
Current: 51.72
During the past 13 years, Samrat Pharmachem's highest Days Inventory was 52.63. The lowest was 22.44. And the median was 34.20.
BOM:530125's Days Inventory is ranked better than 75.06% of 1540
companies
in the Chemicals industry
Industry Median: 80.165
vs BOM:530125: 51.72
Samrat Pharmachem's Days Inventory
increased
from Mar. 2025 (50.42) to Mar. 2026 (56.28).
It might indicate that Samrat Pharmachem's sales slowed down.
Inventory Turnover measures how fast the company turns over its inventory within a year.
Samrat Pharmachem's Inventory Turnover for the
three
months ended in Mar. 2026 was 1.62.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Samrat Pharmachem's Inventory-to-Revenue for the
three
months ended in Mar. 2026 was 0.61.
Samrat Pharmachem (BOM:530125) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
Samrat Pharmachem's Inventory Turnover for the
three
months ended in Mar. 2026 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Samrat Pharmachem's Inventory to Revenue for the
three
months ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
Samrat Pharmachem Days Inventory Related Terms
Samrat Pharmachem Days Inventory Historical Data
* Premium members only.
The historical data trend for Samrat Pharmachem's Days Inventory can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Chemicals subindustry, Samrat Pharmachem's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Samrat Pharmachem Days Inventory vs Chemicals Industry
For the Chemicals industry and Basic Materials sector, Samrat Pharmachem's Days Inventory distribution charts can be found below:
* The bar in red indicates where Samrat Pharmachem's Days Inventory falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Samrat Pharmachem (BOM:530125) has a Days Inventory of 56.28 as of Mar. 2026. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Samrat Pharmachem and its competitors. This is 65% above median its historical median of 34.20. Over the past decade, Samrat Pharmachem's Days Inventory has ranged from 22.44 to 52.63. According to the industry distribution chart, Samrat Pharmachem ranks #384 out of 1540 companies in the Chemicals industry, placing it in the top 24.9%.
Is Samrat Pharmachem's Days Inventory too high?
Samrat Pharmachem's current Days Inventory of 56.28 is 65% above median its 10-year median of 34.20. Over the past 10 years, this metric has ranged from a low of 22.44 to a high of 52.63. The Chemicals industry median Days Inventory is 80.17. Samrat Pharmachem's value of 56.28 is 29.8% below this industry median. Based on the distribution chart, Samrat Pharmachem ranks #384 out of 1540 companies in the Chemicals industry, which is in the top quartile — a strong position relative to peers. Overall, Samrat Pharmachem has a GF Score™ of 64/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Samrat Pharmachem's Days Inventory compare to DOW?
According to the Chemicals industry distribution chart, Samrat Pharmachem ranks #384 out of 1540 companies for Days Inventory. This places Samrat Pharmachem in the top 25% of its industry — outperforming the majority of peers. The industry median Days Inventory is 80.17. Samrat Pharmachem's value of 56.28 is 29.8% below this benchmark. Historically, Samrat Pharmachem's own Days Inventory has ranged from 22.44 to 52.63 over the past decade. While the company's 10-year median is 34.20 vs. the industry median of 80.17, Samrat Pharmachem has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Chemicals company?
The median Days Inventory among Chemicals companies is 80.17, based on 1,540 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Samrat Pharmachem's current Days Inventory of 56.28 is 29.8% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Samrat Pharmachem and its competitors. For the Chemicals industry, the median Days Inventory is 80.17 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Samrat Pharmachem's current Days Inventory is 56.28, which is 65% above median its own 10-year median of 34.20. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Samrat Pharmachem stock overvalued right now?
Based on GuruFocus' analysis, Samrat Pharmachem (BOM:530125) is currently considered Significantly Undervalued. The stock's GF Value™ is ₹362.76, compared to a current price of ₹251.95 — trading 30.5% below its estimated fair value. The current Days Inventory is 56.28, which is 65% above median its 10-year median of 34.20 and 29.8% below the Chemicals industry median of 80.17. Samrat Pharmachem's overall GF Score™ is 64/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For Samrat Pharmachem (BOM:530125), the current Days Inventory is 56.28 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Samrat Pharmachem (BOM:530125) Overvalued in 2026?
Based on GuruFocus' analysis, Samrat Pharmachem stock appears to be undervalued.
The current stock price of ₹251.95 is trading 30.5% below its estimated GF Value™ of ₹362.76.
GuruFocus considers Samrat Pharmachem to be Significantly Undervalued.
Key valuation signals for BOM:530125:
Days Inventory: 56.28 (65% above median its 10-year median of 34.20)
GF Value™: ₹362.76 vs. price of ₹251.95 (30.5% below fair value)
Industry Position: 29.8% below the Chemicals median (#384 of 1540)
No single metric tells the full story. See the BOM:530125 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Samrat Pharmachem Ltd is a producer of pharmaceutical chemicals. The principal activity of the company is to manufacture Iodine salts and bromine salts. Its product portfolio consists of potassium iodate, potassium iodide, methyl iodide, and copper iodide. Its products are used in various industries like pharmaceuticals and chemicals.
64GF Score
Get the complete analysis for BOM:530125
Days Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:530125 has been successfully added to your 
